drugset / Trial / NCT00422734

Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life

NCT00422734

Phase 3 Completed 342 enrolled Eli Lilly and Company ICOS Corporation · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine if tadalafil 5 mg daily compared to placebo when given for 12 weeks improves getting and maintaining an erection in men with erectile dysfunction and if there are improvements in the sexual quality of life of the man and his female study partner

Timeline

Start
2006-11
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 5 mg Oral

Indications